Targeting SNRNP200-Induced Splicing Dysregulation as an Immunotherapy Opportunity for Glycolytic Triple-Negative Breast Cancer

Medicine, Infectious Diseases, Oncology, Life Sciences, Cell Biology, Biochemistry, Immunology, Genetics,
triple-negative breast cancer   SNRNP200   glycolysis   metabolic dysregulation   immunotherapy  

Targeting SNRNP200-Induced Splicing Dysregulation: A New Strategy for Immunotherapy in Glycolytic Triple-Negative Breast Cancer Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by extremely high recurrence and mortality rates. Despite significant recent advances in research on TNBC subty...